Hervé Rhinn

3.1k total citations · 2 hit papers
25 papers, 1.5k citations indexed

About

Hervé Rhinn is a scholar working on Neurology, Neurology and Molecular Biology. According to data from OpenAlex, Hervé Rhinn has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Hervé Rhinn's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Inflammation biomarkers and pathways (5 papers). Hervé Rhinn is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Inflammation biomarkers and pathways (5 papers). Hervé Rhinn collaborates with scholars based in United States, France and Hungary. Hervé Rhinn's co-authors include Asa Abeliovich, Aryeh Zolin, Daniel Scherman, Arnon Rosenthal, Tina Schwabe, Tomoki Kuwahara, Karen Marder, Lawrence S. Honig, Lorraine N. Clark and David MacLeod and has published in prestigious journals such as Nature Communications, Neuron and The Journal of Experimental Medicine.

In The Last Decade

Hervé Rhinn

24 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model

2020 345 citations Shoutang Wang, Carla M. Yuede et al. The Journal of Experimental Medicine profile →
Progranulin as a therapeutic target in neurodegenerative diseases

2022 104 citations Hervé Rhinn, Nadine Tatton et al. Trends in Pharmacological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hervé Rhinn United States	15	527	512	510	485	247	25	1.5k
Satoshi Tsunoda Japan	17	648 1.2×	1.0k 2.0×	630 1.2×	173 0.4×	169 0.7×	30	2.1k
Xiaolai Zhou United States	20	468 0.9×	333 0.7×	398 0.8×	668 1.4×	111 0.4×	29	1.3k
Ji-Hoon Cho United States	11	388 0.7×	585 1.1×	334 0.7×	447 0.9×	91 0.4×	21	1.4k
Kristina R. Patterson United States	12	769 1.5×	531 1.0×	228 0.4×	400 0.8×	156 0.6×	19	1.5k
Yuka Atagi United States	12	849 1.6×	522 1.0×	894 1.8×	232 0.5×	164 0.7×	13	1.8k
Insup Choi United States	18	325 0.6×	409 0.8×	455 0.9×	515 1.1×	120 0.5×	21	1.2k
Jorge Marcondes de Souza Brazil	21	287 0.5×	481 0.9×	411 0.8×	414 0.9×	68 0.3×	70	1.8k
Yiting Liu China	15	241 0.5×	687 1.3×	541 1.1×	336 0.7×	94 0.4×	33	1.9k
Linda Moran United Kingdom	19	294 0.6×	574 1.1×	558 1.1×	810 1.7×	133 0.5×	39	1.8k
Subhas C. Biswas India	23	404 0.8×	1.1k 2.2×	185 0.4×	186 0.4×	205 0.8×	59	1.8k

Countries citing papers authored by Hervé Rhinn

Since Specialization

Citations

This map shows the geographic impact of Hervé Rhinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Rhinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Rhinn more than expected).

Fields of papers citing papers by Hervé Rhinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Rhinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Rhinn. The network helps show where Hervé Rhinn may publish in the future.

Co-authorship network of co-authors of Hervé Rhinn

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Rhinn. A scholar is included among the top collaborators of Hervé Rhinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Rhinn. Hervé Rhinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Long, Hua, Adam Simmons, Arthur J. Mayorga, et al.. (2024). Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease. Alzheimer s Research & Therapy. 16(1). 235–235. 38 indexed citations

2.

Rhinn, Hervé, et al.. (2022). Progranulin as a therapeutic target in neurodegenerative diseases. Trends in Pharmacological Sciences. 43(8). 641–652. 104 indexed citations breakdown →

3.

Huang, Julie Y., Robert Paul, Felix L. Yeh, et al.. (2022). A Phase 2 Study of AL001 in Frontotemporal Dementia Patients Carrying a Granulin Mutation (P5-3.005). Neurology. 98(18_supplement). 2 indexed citations

4.

Yang, Chengran, Anne M. Fagan, Richard J. Perrin, et al.. (2022). Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Medicine. 14(1). 140–140. 18 indexed citations

5.

Jackson, Sam, Felix L. Yeh, Michael E. Ward, et al.. (2021). Six months interim analysis of the phase 2 study of AL001 in frontotemporal dementia patients carrying a granulin mutation. Alzheimer s & Dementia. 17(S9). 1 indexed citations

6.

Sung, Yun Ju, Chengran Yang, Hervé Rhinn, et al.. (2021). Multi‐tissue proteomic profiling for genetically defined Alzheimer disease cases. Alzheimer s & Dementia. 17(S5).

7.

Wang, Shoutang, Carla M. Yuede, Santiago V. Salazar, et al.. (2020). Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model. The Journal of Experimental Medicine. 217(9). 345 indexed citations breakdown →

8.

Schwabe, Tina, Karpagam Srinivasan, & Hervé Rhinn. (2020). Shifting paradigms: The central role of microglia in Alzheimer's disease. Neurobiology of Disease. 143. 104962–104962. 58 indexed citations

9.

Long, Hua, et al.. (2019). O1‐08‐04: PRECLINICAL DEVELOPMENT OF TREM2 AGONIST ANTIBODY (AL002) IN CYNOMOLGUS MONKEYS. Alzheimer s & Dementia. 15(7S_Part_4). 2 indexed citations

10.

Rhinn, Hervé & Asa Abeliovich. (2017). Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes. Cell Systems. 4(4). 404–415.e5. 82 indexed citations

11.

MacLeod, David, Hervé Rhinn, Tomoki Kuwahara, et al.. (2013). RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk. Neuron. 77(5). 994–994. 2 indexed citations

12.

MacLeod, David, Hervé Rhinn, Tomoki Kuwahara, et al.. (2013). RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk. Neuron. 79(1). 202–203. 20 indexed citations

13.

MacLeod, David, Hervé Rhinn, Tomoki Kuwahara, et al.. (2013). RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk. Neuron. 77(3). 425–439. 414 indexed citations

14.

Rhinn, Hervé, Liang Qiang, Toru Yamashita, et al.. (2012). Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. Nature Communications. 3(1). 1084–1084. 110 indexed citations

15.

Rhinn, Hervé, et al.. (2011). Identification and Induction of Cytochrome P450s Involved in the Metabolism of Flavone-8-Acetic Acid in Mice. Drug Metabolism Letters. 5(2). 73–84. 5 indexed citations

16.

Rhinn, Hervé, Céline Largeau, Pascal Bigey, et al.. (2009). How to make siRNA lipoplexes efficient? Add a DNA cargo. Biochimica et Biophysica Acta (BBA) - General Subjects. 1790(4). 219–230. 30 indexed citations

17.

Rhinn, Hervé, Catherine Marchand‐Leroux, Nicole Croci, et al.. (2008). Housekeeping while brain's storming Validation of normalizing factors for gene expression studies in a murine model of traumatic brain injury. BMC Molecular Biology. 9(1). 62–62. 56 indexed citations

18.

Rhinn, Hervé, Daniel Scherman, & Virginie Escriou. (2007). One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler. Analytical Biochemistry. 372(1). 116–118. 44 indexed citations

19.

Khoury, Maroun, Pascal Bigey, Pascale Louis‐Plence, et al.. (2006). A comparative study on intra‐articular versus systemic gene electrotransfer in experimental arthritis. The Journal of Gene Medicine. 8(8). 1027–1036. 28 indexed citations

20.

Haddad, M., Hervé Rhinn, Carole Bloquel, et al.. (2006). Anti‐inflammatory effects of PJ34, a poly(ADP‐ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. British Journal of Pharmacology. 149(1). 23–30. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact